BioXcel Therapeutics Inc Defensive Interval Ratio
BioXcel Therapeutics Inc defensive interval ratio. BioXcel Therapeutics Inc (BTAI) has a Defensive Interval Ratio of 0 days as of June 2026. Defensive assets of $82.00K (cash $-, short-term investments $-, receivables $82.00K) cover 0 days of daily cash needs of $375.75K/day. See BioXcel Therapeutics Inc (BTAI) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of BioXcel Therapeutics Inc (2018–2025)
Defensive interval ratio of BioXcel Therapeutics Inc from 2018 to 2025. This chart shows how BioXcel Therapeutics Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 0 days, meaning defensive assets of $82.00K can fund 0 days of operations without new revenue. Check BTAI asset resilience ratio to evaluate the company's liquid asset resilience ratio.
BioXcel Therapeutics Inc Defensive Interval Ratio by Year (2018–2025)
BioXcel Therapeutics Inc defensive interval ratio by year from 2018 to 2025. The table below presents the year-by-year Defensive Interval Ratio for BioXcel Therapeutics Inc from 2018 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see how large is BioXcel Therapeutics Inc's balance sheet.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2 days | $233.00K | $147.74K/day | $- | $- | ▼ -1 days |
| 2024 | 2 days | $131.00K | $60.91K/day | $- | $- | ▲ +1 days |
| 2023 | 1 days | $71.00K | $74.70K/day | $- | $- | ▼ -2 days |
| 2022 | 3 days | $248.00K | $90.13K/day | $- | $- | ▲ +3 days |
| 2021 | 0 days | $0.00 | $45.66K/day | $- | $- | ▼ -9 days |
| 2018 | 9 days | $115.00K | $12.77K/day | $- | $- | — |